about
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptidesNew design of MHC class II tetramers to accommodate fundamental principles of antigen presentationCell surface display of functional human MHC class II proteins: yeast display versus insect cell displayViral-specific adoptive immunotherapy after allo-SCT: the role of multimer-based selection strategies.MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology"
P2860
description
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2002
@uk
name
Frontiers in peptide–MHC class II multimer technology
@en
Frontiers in peptide–MHC class II multimer technology
@nl
type
label
Frontiers in peptide–MHC class II multimer technology
@en
Frontiers in peptide–MHC class II multimer technology
@nl
prefLabel
Frontiers in peptide–MHC class II multimer technology
@en
Frontiers in peptide–MHC class II multimer technology
@nl
P356
P1433
P1476
Frontiers in peptide–MHC class II multimer technology
@en
P2093
Opendra K. Sharma
P304
P356
10.1038/NI1002-887
P407
P577
2002-10-01T00:00:00Z